{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T22:37:07Z","timestamp":1720564627775},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","medical-hypotheses.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.mehy.2016.05.032","type":"journal-article","created":{"date-parts":[[2016,5,28]],"date-time":"2016-05-28T20:26:45Z","timestamp":1464467205000},"page":"113-116","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Chemogenetic approach to model hypofrontality"],"prefix":"10.1016","volume":"93","author":[{"given":"Ike dela","family":"Pe\u00f1a","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Xing","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.mehy.2016.05.032_b0005","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1001\/archpsyc.1987.01800190080012","article-title":"Implications of normal brain development for the pathogenesis of schizophrenia","volume":"44","author":"Weinberger","year":"1987","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"10.1016\/j.mehy.2016.05.032_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0306-4522(91)90196-U","article-title":"Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia","volume":"41","author":"Grace","year":"1991","journal-title":"Neuroscience"},{"key":"10.1016\/j.mehy.2016.05.032_b0015","doi-asserted-by":"crossref","first-page":"S465","DOI":"10.1038\/bjp.2008.24","article-title":"Modeling prefrontal cortex deficits in schizophrenia: implications for treatment","volume":"153","author":"Pratt","year":"2008","journal-title":"Br J Pharmacol"},{"issue":"4","key":"10.1016\/j.mehy.2016.05.032_b0020","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1177\/0269881113512909","article-title":"Reviewing the ketamine model for schizophrenia","volume":"28","author":"Frohlich","year":"2014","journal-title":"J Psychopharmacol"},{"issue":"2","key":"10.1016\/j.mehy.2016.05.032_b0025","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/schbul\/sbp133","article-title":"Review of pathological hallmarks of schizophrenia: comparison of genetic models with patients and nongenetic models","volume":"36","author":"Jaaro-Peled","year":"2010","journal-title":"Schizophr Bull"},{"issue":"4","key":"10.1016\/j.mehy.2016.05.032_b0030","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/j.1476-5381.2011.01386.x","article-title":"Animal models of schizophrenia","volume":"164","author":"Jones","year":"2011","journal-title":"Br J Pharmacol"},{"issue":"2","key":"10.1016\/j.mehy.2016.05.032_b0035","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyu013","article-title":"Prefrontal cortical GABA modulation of spatial reference and working memory","volume":"18","author":"Auger","year":"2014","journal-title":"Int J Neuropsychopharmacol"},{"issue":"2","key":"10.1016\/j.mehy.2016.05.032_b0040","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00213-010-2055-9","article-title":"Prefrontal stimulation of GABAA receptors counteracts the corticolimbic hyperactivity produced by NMDA antagonists in the prefrontal cortex of the rat","volume":"214","author":"Del Arco","year":"2011","journal-title":"Psychopharmacology"},{"issue":"23","key":"10.1016\/j.mehy.2016.05.032_b0045","doi-asserted-by":"crossref","first-page":"7931","DOI":"10.1523\/JNEUROSCI.3450-13.2014","article-title":"Too little and too much: hypoactivation and disinhibition of medial prefrontal cortex cause attentional deficits","volume":"34","author":"Pezze","year":"2014","journal-title":"J Neurosci"},{"issue":"24","key":"10.1016\/j.mehy.2016.05.032_b0050","doi-asserted-by":"crossref","first-page":"4481","DOI":"10.1007\/s00213-015-4075-y","article-title":"Inactivation of the prelimbic or infralimbic cortex impairs decision-making in the rat gambling task","volume":"232","author":"Zeeb","year":"2015","journal-title":"Psychopharmacology"},{"issue":"5","key":"10.1016\/j.mehy.2016.05.032_b0055","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0893-133X(96)00052-8","article-title":"Effects of lesions in the medial prefrontal cortex on the activity of midbrain dopamine neurons","volume":"15","author":"Shim","year":"1996","journal-title":"Neuropsychopharmacology"},{"issue":"19","key":"10.1016\/j.mehy.2016.05.032_b0060","doi-asserted-by":"crossref","first-page":"8159","DOI":"10.1523\/JNEUROSCI.0118-13.2013","article-title":"Effects of prefrontal cortical inactivation on neural activity in the ventral tegmental area","volume":"33","author":"Jo","year":"2013","journal-title":"J Neurosci"},{"issue":"564","key":"10.1016\/j.mehy.2016.05.032_b0065","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.neulet.2014.01.032","article-title":"Chronic phencyclidine treatment induces long-lasting glutamatergic activation of VTA dopamine neurons","volume":"3","author":"Uramura","year":"2014","journal-title":"Neurosci Lett."},{"issue":"9","key":"10.1016\/j.mehy.2016.05.032_b0070","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/0028-3908(87)90087-6","article-title":"Electrophysiological effects of phencyclidine in the medial prefrontal cortex of the rat","volume":"26","author":"Gratton","year":"1987","journal-title":"Neuropharmacology"},{"issue":"43","key":"10.1016\/j.mehy.2016.05.032_b0075","doi-asserted-by":"crossref","first-page":"11496","DOI":"10.1523\/JNEUROSCI.2213-07.2007","article-title":"NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons","volume":"27","author":"Homayoun","year":"2007","journal-title":"J Neurosci"},{"issue":"37","key":"10.1016\/j.mehy.2016.05.032_b0080","doi-asserted-by":"crossref","first-page":"14843","DOI":"10.1073\/pnas.0704848104","article-title":"Antipsychotic drugs reverse the disruption in prefrontal cortex function produced by NMDA receptor blockade with phencyclidine","volume":"104","author":"Kargieman","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"10.1016\/j.mehy.2016.05.032_b0085","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1080\/08039480902767286","article-title":"Is schizophrenia a neurodegenerative disorder?","volume":"63","author":"Rund","year":"2009","journal-title":"Nord J Psychiatry"},{"issue":"6","key":"10.1016\/j.mehy.2016.05.032_b0090","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1001\/archpsyc.59.6.553","article-title":"Neurotoxicity, neuroplasticity, and magnetic resonance imaging morphometry: what is happening in the schizophrenic brain?","volume":"59","author":"Weinberger","year":"2002","journal-title":"Arch Gen Psychiatry"},{"issue":"9","key":"10.1016\/j.mehy.2016.05.032_b0095","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1038\/nn.4091","article-title":"Optogenetics: 10years of microbial opsins in neuroscience","volume":"8","author":"Deisseroth","year":"2015","journal-title":"Nat Neurosci"},{"issue":"1","key":"10.1016\/j.mehy.2016.05.032_b0100","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/npp.2011.179","article-title":"Grateful DREADDs: engineered receptors reveal how neural circuits regulate behavior","volume":"37","author":"Ferguson","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.mehy.2016.05.032_b0105","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1124\/pr.110.003020","article-title":"Remote control of neuronal signaling","volume":"63","author":"Rogan","year":"2011","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.mehy.2016.05.032_b0110","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1146\/annurev-pharmtox-010814-124803","article-title":"DREADDs (designer receptors exclusively activated by designer drugs): chemogenetic tools with therapeutic utility","volume":"55","author":"Urban","year":"2015","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.mehy.2016.05.032_b0115","doi-asserted-by":"crossref","first-page":"5163","DOI":"10.1073\/pnas.0700293104","article-title":"Evolving the lock to fit the key to create a family of G protein-coupled receptors potently activated by an inert ligand","volume":"104","author":"Armbruster","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.mehy.2016.05.032_b0120","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.neuron.2009.06.014","article-title":"Remote control of neuronal activity in transgenic mice expressing evolved G protein-coupled receptors","volume":"63","author":"Alexander","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.mehy.2016.05.032_b0125","doi-asserted-by":"crossref","unstructured":"Koike H, Demars MP, Short JA, et al. Chemogenetic inactivation of dorsal anterior cingulate cortex neurons disrupts attentional behavior in mouse. Neuropsychopharmacology (in press).","DOI":"10.1038\/npp.2015.229"},{"issue":"2","key":"10.1016\/j.mehy.2016.05.032_b0130","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/npp.2013.184","article-title":"Reverse pharmacogenetic modulation of the nucleus accumbens reduces ethanol consumption in a limited access paradigm","volume":"39","author":"Cassataro","year":"2014","journal-title":"Neuropsychopharmacology"},{"issue":"20","key":"10.1016\/j.mehy.2016.05.032_b0135","doi-asserted-by":"crossref","first-page":"5414","DOI":"10.1523\/JNEUROSCI.5347-06.2007","article-title":"Functional coupling between the prefrontal cortex and dopamine neurons in the ventral tegmental area","volume":"27","author":"Gao","year":"2007","journal-title":"J. Neurosci"},{"issue":"3","key":"10.1016\/j.mehy.2016.05.032_b0140","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/(SICI)1098-2396(199603)22:3<195::AID-SYN1>3.0.CO;2-7","article-title":"Stimulation of the prefrontal cortex in the rat induces patterns of activity in midbrain dopaminergic neurons which resemble natural burst events","volume":"22","author":"Tong","year":"1996","journal-title":"Synapse"},{"issue":"8","key":"10.1016\/j.mehy.2016.05.032_b0145","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/j.pnpbp.2007.08.025","article-title":"The amphetamine-induced sensitized state as a model of schizophrenia","volume":"31","author":"Featherstone","year":"2007","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"4","key":"10.1016\/j.mehy.2016.05.032_b0150","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1111\/j.1460-9568.2007.05738.x","article-title":"Activation of afferents to the ventral tegmental area in response to acute amphetamine: a double labeling study","volume":"26","author":"Colussi-Mas","year":"2007","journal-title":"Eur J Neurosci"},{"issue":"4","key":"10.1016\/j.mehy.2016.05.032_b0155","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.neuropharm.2011.04.026","article-title":"Sensitized activation of Fos and brain-derived neurotrophic factor in the medial prefrontal cortex and ventral tegmental area accompanies behavioral sensitization to amphetamine","volume":"61","author":"Fanous","year":"2011","journal-title":"Neuropharmacology"},{"issue":"2\u20133","key":"10.1016\/j.mehy.2016.05.032_b0160","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0165-0173(99)00054-5","article-title":"The role of endogenous sensitization in the pathophysiology of schizophrenia: implications from recent brain imaging studies","volume":"31","author":"Laruelle","year":"2000","journal-title":"Brain Res Rev"},{"issue":"4","key":"10.1016\/j.mehy.2016.05.032_b0165","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/npp.2015.253","article-title":"Corticostriatal afferents modulate responsiveness to psychostimulant drugs and drug-associated stimuli","volume":"41","author":"Kerstetter","year":"2016","journal-title":"Neuropsychopharmacology"},{"issue":"6075","key":"10.1016\/j.mehy.2016.05.032_b0170","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1126\/science.1214985","article-title":"Generation of a synthetic memory trace","volume":"335","author":"Garner","year":"2012","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.mehy.2016.05.032_b0175","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nn.3957","article-title":"Neuronal ensembles sufficient for recovery sleep and the sedative actions of a2 adrenergic agonists","volume":"18","author":"Zhang","year":"2015","journal-title":"Nat Neurosci"},{"issue":"6","key":"10.1016\/j.mehy.2016.05.032_b0180","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/nrn2648","article-title":"Stress signalling pathways that impair prefrontal cortex structure and function","volume":"10","author":"Arnsten","year":"2009","journal-title":"Nat Rev Neurosci"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987716301815?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987716301815?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T00:56:40Z","timestamp":1567990600000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987716301815"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":36,"alternative-id":["S0306987716301815"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2016.05.032","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chemogenetic approach to model hypofrontality","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2016.05.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}